These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8682957

  • 1. Acquired ichthyosis in bone marrow transplant recipients.
    Spelman LJ, Strutton GM, Robertson IM, Weedon D.
    J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
    [Abstract] [Full Text] [Related]

  • 2. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Dilek I, Demirer T, Ustün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Ozcan M, Ilhan O, Akan H.
    Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.
    Baker KS, Loberiza FR, Yu H, Cairo MS, Bolwell BJ, Bujan-Boza WA, Camitta BM, Garcia JJ, Ho WG, Liesveld JL, Maharaj D, Marks DI, Schultz KR, Wiernik P, Zander AR, Horowitz MM, Keating A, Weisdorf DJ.
    J Clin Oncol; 2005 Oct 01; 23(28):7032-42. PubMed ID: 16145067
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
    Marra DE, McKee PH, Nghiem P.
    J Am Acad Dermatol; 2004 Oct 01; 51(4):543-6. PubMed ID: 15389188
    [Abstract] [Full Text] [Related]

  • 9. Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry.
    Bortin MM, Horowitz MM, Gale RP.
    Nat Immun Cell Growth Regul; 1988 Oct 01; 7(5-6):334-50. PubMed ID: 3065641
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dermatologic changes associated with roquinimex immunotherapy after autologous bone marrow transplant.
    Ohsuga Y, Rowe JM, Liesveld J, Burns RP, Gaspari AA.
    J Am Acad Dermatol; 2000 Sep 01; 43(3):437-41. PubMed ID: 10954654
    [Abstract] [Full Text] [Related]

  • 20. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
    Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M.
    Bone Marrow Transplant; 2004 Oct 01; 34(8):721-7. PubMed ID: 15322568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.